HomeLSB • NASDAQ
add
LakeShore Biopharma Co Ltd
Previous close
$2.60
Day range
$2.40 - $2.70
Year range
$0.37 - $2.70
Market cap
49.99M USD
Avg Volume
61.74K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 135.35M | 27.67% |
Operating expense | 127.53M | -14.79% |
Net income | -181.17M | -63.27% |
Net profit margin | -133.85 | -27.88% |
Earnings per share | -13.40 | — |
EBITDA | -82.62M | -48.59% |
Effective tax rate | 6.92% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 246.35M | -33.44% |
Total assets | 1.51B | -12.02% |
Total liabilities | 927.82M | -6.40% |
Total equity | 585.21M | — |
Shares outstanding | 19.08M | — |
Price to book | 0.08 | — |
Return on assets | -15.41% | — |
Return on capital | -22.81% | — |
Cash Flow
Net change in cash
(CNY) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -181.17M | -63.27% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
2002
Website
Employees
758